Guidelines on the use of irradiated blood components

Theodora Foukaneli^{1

2}, Paul Kerr³, Paula H B Bolton-Maggs^{4

5}, Rebecca Cardigan⁶, Alasdair Coles⁷, Andrew Gennery⁸, David Jane⁹, Dinakantha Kumararatne¹⁰, Ania Manson¹⁰, Helen V New^{11

12}, Nicholas Torpey¹³; BCSH Committee

Affiliations

¹ NHS Blood and Transplant Cambridge, Cambridge, UK.
² Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
³ Department of Haematology, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK.
⁴ Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
⁵ Serious Hazards of Transfusion Office, Manchester Blood Centre, Manchester, UK.
⁶ Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
⁷ Clinical Neuroscience, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
⁸ Department of Paediatric Immunology, Institute of Cellular Medicine, Newcastle University, Cambridge, Newcastle upon Tyne, UK.
⁹ Department of Medicine, University of Cambridge, Cambridge Biomedical Campus Cambridge, Cambridge, UK.
¹⁰ Department of Clinical Immunology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
¹¹ NHS Blood and Transplant, London, UK.
¹² Department of Haematology, Imperial College London, London, UK.
¹³ Department of Clinical Nephrology and Transplantation, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Practice Guideline

Theodora Foukaneli et al. Br J Haematol. 2020 Dec.

. 2020 Dec;191(5):704-724.

doi: 10.1111/bjh.17015. Epub 2020 Aug 18.

¹ NHS Blood and Transplant Cambridge, Cambridge, UK.
² Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
³ Department of Haematology, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK.
⁴ Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
⁵ Serious Hazards of Transfusion Office, Manchester Blood Centre, Manchester, UK.
⁶ Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
⁷ Clinical Neuroscience, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
⁸ Department of Paediatric Immunology, Institute of Cellular Medicine, Newcastle University, Cambridge, Newcastle upon Tyne, UK.
⁹ Department of Medicine, University of Cambridge, Cambridge Biomedical Campus Cambridge, Cambridge, UK.
¹⁰ Department of Clinical Immunology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
¹¹ NHS Blood and Transplant, London, UK.
¹² Department of Haematology, Imperial College London, London, UK.
¹³ Department of Clinical Nephrology and Transplantation, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

No abstract available

Comment in

Preventing transfusion-associated graft-versus-host disease with blood component irradiation: indispensable guidance for a deadly disorder.
Ní Loingsigh S, Flegel WA, Hendrickson JE, Tormey CA. Ní Loingsigh S, et al. Br J Haematol. 2020 Dec;191(5):653-657. doi: 10.1111/bjh.17016. Epub 2020 Aug 1. Br J Haematol. 2020. PMID: 32738068 Free PMC article. No abstract available.
BSH guidelines for the use of irradiated blood components: guidance that is needed.
Shehata N. Shehata N. Br J Haematol. 2020 Dec;191(5):658-660. doi: 10.1111/bjh.17150. Epub 2020 Nov 5. Br J Haematol. 2020. PMID: 33152100 No abstract available.

1. Anderson KC, Weinstein HJ. Transfusion-associated graft-versus-host disease. N Engl J Med. 1990;323:315-21.
1. Burns LJ, Westberg MW, Burns CP, Klassen LW, Goeken NE, Ray TL, et al. Acute graft-versus-host disease resulting from normal donor blood transfusions. Acta Haematol. 1984;71:270-6.
1. Von Fliedner V, Higby DJ, Kim U. Graft-versus-host reaction following blood product transfusion. Am J Med. 1982;72:951-61.
1. Agbaht K, Altintas ND, Topeli A, Gokoz O, Ozcebe O. Transfusion-associated graft-versus-host disease in immunocompetent patients: case series and review of the literature. Transfusion. 2007;47:1405-11.
1. Aoun E, Shamseddine A, Chehal A, Obei M, Taher A. Transfusion-associated GVHD: 10 years’ experience at the American University of Beirut-Medical Center. Transfusion. 2003;43:1672-6.